BGAM
BIIB icon

Boussard & Gavaudan Asset Management’s Biogen BIIB Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,300
Closed -$394K – 115
2014
Q1 		$394K Buy
+1,300
New +$413K 0.24% 10

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boussard & Gavaudan Asset Management's BIIB Position: Q2 2014 in Review

Boussard & Gavaudan Asset Management sold out of Biogen (BIIB) in Q2 2014, closing a stake of 1,300 shares — an estimated $394K sold.

Boussard & Gavaudan Asset Management first reported a position in BIIB in Q1 2014 and held it in 1 quarter. The position peaked at $394K in Q1 2014. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Biogen position as of Q2 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 1,300 Biogen shares in Q2 2014, an estimated $394K.
  • Boussard & Gavaudan Asset Management first reported a position in Biogen in Q1 2014 and held it in 1 quarter.
  • Boussard & Gavaudan Asset Management's Biogen position peaked at $394K in Q1 2014.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q2 2014, filed 1 Aug 2014.